Preimplantation Genetic Diagnosis (PGD) Market is Expected to Reach USD 47.4 Million Globally in 2018: Transparency Market Research

Informations

• Publié par: transparency-market-research
• Nombre de lectures: 22
• Langue: English

Extrait

Preimplantation Genetic Diagnosis (PGD) Market is Expected to Reach USD 47.4 Million Globally in 2018: Transparency Market Research

PR Newswire ALBANY, New York, October 29, 2012

ALBANY, New York,October 29, 2012/PRNewswire/ --

According to the latest market report published by Transparency Market Research (http://www.transparencymarketresearch.com) "Preimplantation Genetic Diagnosis (PGD) Market - Global Industry Analysis, Market Size, Market Share & Forecast 2012 - 2018," the global pre-implantation genetic diagnosis market was estimated to be worthUSD 31.9 millionin 2011 and is expected to reachUSD 47.4 millionin 2018, growing at a CAGR of 6.2% from 2013 to 2018. North America dominates the global demand for PGD, and is expected to account for over 30% of the global market followed by Europe at 28% in 2018.

Browse the full report athttp://www.transparencymarketresearch.com/preimplan tation-genetic-diagnosis- market.html

Some of the major drivers of theglobal PGD marketare increase in the scope of direct to consumer genetic testing methods, increase in the number of cases of genetic diseases, the rising rate of infertility and the efficiency of PGD in assisting successful fetal implantation. PGD is adjunct to in vitro fertilization (IVF) and is employed for detection of any genetic abnormality in the embryo before it is implanted through IVF.

The major types of PGD testing are for determination of chromosomal abnormalities, detection of aneuploidy, HLA typing, gender selection and others. The major market for PGD exists in developed countries. However, emerging markets in the developing nations of Asia and rest of the world will grow with the advent of genetic diagnosis technology and awareness about prevention of genetic disorders.

Over the last decade, the demand for PGD has grown significantly, mostly owing to the growing awareness regarding the prevention of genetic diseases and the increase in the number of genetic disorders which can be diagnosed through PGD. Major opportunities which can be tapped for inducing further growth of the PGD market are innovations in the field of diagnosis of genetically inherited cancer and innovations in genetic diagnosis.

Related & Recently Published Reports by Transparency Market Research

Prostate Cancer Market

Global Osteoporosis Market

Global Nutraceuticals Product Market

Global Nutraceuticals Ingredients Market

Global Surgical Equipment Industry

COPD Drugs Industry

Global Spectrometry Industry

Circulating Tumor Cells Market

Synthetic Biology Industry

U.S. Vaccine Industry

Insulin Devices Market

Home Health Care Industry

Ecc Procedures Industry

The prime geographical markets for PGD are Europe and North America. It is expected that North America will lead the PGD market in terms of market share and revenue by 2018. Asia and rest of the world will also grow at a fast yet steady pace and make their mark in the global PGD m arket.

This research is specially designed to estimate and analyze the demand for preimplantation genetic diagnosis in the global market. The research provides in-depth analysis of preimplantation genetic diagnosis service providers, the product sales, segment wise trend analysis and the demand of PGD by geography. High level analysis of the

segments of the global PGD market is performed and the report provides detailed analysis, comprehensive historical data and statistically tested forecast of the segments thus covered. A comprehensive assessment of the strategies of the participants of the market and the winning imperatives for them has been analyzed by segmenting the global preimplantation genetic diagnosis market as below:

Preimplantation genetic diagnosis market by product types

- For determination of chromosomal abnormalities

- Aneuploidy

- HLA typing

- Gender selection

- X-linked diseases

- Single gene disorders

- Other geneticdisorders

Preimplantation genetic diagnosis market by application

- Determination of HLA compatible embryos for stem cell therapy

- Late-onset genetic disorders

- Improving prognosis for in vitro fertilization patients

- Inherited genetic diseases

- Others

In addition a detailed cross sectional analysis of the above segments with respect to the following geographical markets has been performed:

- North America

- Europe

- Asia

- Rest of the World (RoW)

Browse allPharmaceuticalMarketResearch Reports

Upcoming Reports inPharmaceuticalMarket

Membrane Bioreactor (MBR) Market

Smart Pill Technology Market

Biosimulation Market

Bioinformatics Market

Neuromodulation Devices Market

Hormone Replacement Therapy Market

Agricultural Biotechnology Market

Acute Myeloid Leukemia (AML) Therapeutics Market

Freeze Drying Equipment Market

Antibiotic Market

About Us

Transparency Market Research is a global market intelligence company, providing global business inform ation reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Sheela AK 90 Sate Street, Suite 700 Albany, NY 12207 Tel: [phone] USA - Canada Toll Free: 866-552-3453 Email:[e-mail] Podcast:http://transparencymarketresearch.podbean.com/ Search Reports:http://www.mrrse.com/